Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes

Completed · Not applicable

Conditions studied: Parkinson Disease

In brief

Connect.Parkinson is a randomized comparative effectiveness study, comparing usual care enhanced with educational materials to usual care, educational materials, and the delivery of specialty care via telemedicine into patient's homes. The study's specific aims are the following: 1. To demonstrate the feasibility of using telemedicine to deliver specialty care into the homes of individuals with Parkinson disease who have limited access to care; 2. To show that such an approach can improve quality of life; 3. To establish that the telemedicine can enhance the quality of care; and 4. To demonstrate that this remote approach to care saves time, reduces travel, and decreases care partner burden.

Key facts

Study ID

NCT02038959

Run by

University of Rochester

People needed

210

Starts

2014-03-01

Expected to finish

2016-08-01

Last updated by the study team

2017-01-27

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Individuals with clinically diagnosed Idiopathic Parkinson disease in the judgment of the independent rater
• No better alternative explanation for the parkinsonism
• Access to a non-public, internet-enabled device (e.g., computer, tablet computer, smart phone) that has the capacity for web-based video conferencing
• Be physically located at time visits are conducted in a state where the participating physician is licensed to practice medicine
• Have a local care provider that the study team can contact
• Live at home, in a senior housing complex, or assisted living facility
• Be fluent in English (all participating states) or Spanish (participants in Florida and Massachusetts only)
• Willing and able to provide informed consent
• Care partner (if applicable) must be able and willing to provide informed consent to participate if he or she so chooses.

You may not qualify if…

• Currently hospitalized
• Condition (e.g., prominent psychosis) that precludes study participation as identified by the medical professional (site investigator or nurse).
• Participation in another telemedicine study.

Where it is running

• University of California San Francisco — San Francisco, California, United States
• The Parkinson's Institute and Clinical Center — Sunnyvale, California, United States
• University of Florida — Gainsville, Florida, United States
• University of Miami — Miami, Florida, United States
• Georgia Regents University — Augusta, Georgia, United States
• Northwestern University — Chicago, Illinois, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• Johns Hopkins — Baltimore, Maryland, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Struthers Parkinson Center — Golden Valley, Minnesota, United States
• The Mayo Clinic — Rochester, Minnesota, United States
• Northshore Long Island Jewish - Feinstein Institute — Manhasset, New York, United States
• University of Rochester Medical Center — Rochester, New York, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Oregon Health & Science University — Portland, Oregon, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Baylor College of Medicine — Houston, Texas, United States
• Northwest Neurological, PLLC — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.